---
figid: PMC8533513__biomedicines-09-01491-g002
figtitle: Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral
  Treatments
organisms:
- Hepatitis C virus genotype 1
- Hepatitis C virus genotype 3
- Homo sapiens
- Mus musculus
- NA
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC8533513
filename: biomedicines-09-01491-g002.jpg
figlink: /pmc/articles/PMC8533513/figure/biomedicines-09-01491-f002/
number: F2
caption: 'Extrahepatic disorders associated with hepatitis C virus. Red and green
  illustrate upregulation and downregulation, respectively. HCV: hepatitis C virus;
  TNF-α: tumor necrosis factor alpha; SOCS3: suppressor of cytokine signaling 3; IRS-1:
  insulin receptor substrate signaling 1; IRS-2: insulin receptor substrate signaling
  2; AKT: protein kinase B or Akt signaling pathway; MAPK: mitogen-activated protein
  kinase signaling pathway; CVD: cardiovascular disease; MetS: metabolic syndrome;
  T2D: type 2 diabetes.'
papertitle: The Impact of Steatosis on Chronic Hepatitis C Progression and Response
  to Antiviral Treatments.
reftext: Phumelele Yvonne Siphepho, et al. Biomedicines. 2021 Oct;9(10):1491.
year: '2021'
doi: 10.3390/biomedicines9101491
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI
keywords: hepatitis C virus | steatosis | NAFLD/NASH (MAFLD) | metabolic syndrome
  | hepatocellular carcinoma | interferon-based therapy | interferon-free direct-acting
  antivirals
automl_pathway: 0.9185694
figid_alias: PMC8533513__F2
figtype: Figure
redirect_from: /figures/PMC8533513__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8533513__biomedicines-09-01491-g002.html
  '@type': Dataset
  description: 'Extrahepatic disorders associated with hepatitis C virus. Red and
    green illustrate upregulation and downregulation, respectively. HCV: hepatitis
    C virus; TNF-α: tumor necrosis factor alpha; SOCS3: suppressor of cytokine signaling
    3; IRS-1: insulin receptor substrate signaling 1; IRS-2: insulin receptor substrate
    signaling 2; AKT: protein kinase B or Akt signaling pathway; MAPK: mitogen-activated
    protein kinase signaling pathway; CVD: cardiovascular disease; MetS: metabolic
    syndrome; T2D: type 2 diabetes.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - IRS1
  - SOCS3
  - IRS2
  - SGSM3
  - AKT1
  - AKT2
  - AKT3
  - ETV3
  - SLC2A4
  - NEUROD1
  - HNF1B
  - Tnf
  - Irs1
  - Socs3
  - Irs2
  - Akt1
  - Etv3
  - Slc2a4
  - tnfb
  - irs1
  - socs3a
  - irs2b
  - pak2a
  - itpka
---
